Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Malignant Solid Neoplasm × Practice Guidelines as Topic × Clear all

Sponsor

Conditions

Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Breast Neoplasms 3 Urinary Bladder Neoplasms 2 Prostatic Neoplasms 2 Neoplasms 2 Colorectal Neoplasms 2 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Sarcoma 1 Recurrence 1 Rectal Neoplasms 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Multiple Endocrine Neoplasia Type 1 1 Melanoma 1 Lung Neoplasms 1 Localized Prostate Carcinoma 1 Leukemia, Myeloid, Acute 1 Hepatitis B 1 Hematologic Neoplasms 1 Gastrointestinal Neoplasms 1 Esophageal Neoplasms 1 Endometrial Clear Cell Adenocarcinoma 1 Disease Progression 1 Digestive System Carcinoma 1 Communication 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Specimen Handling 3 Biopsy 3 X-Rays 2 trastuzumab biosimilar HLX02 1 pertuzumab 1 erdafitinib 1 copanlisib 1 Trastuzumab 1 PF-05280014 1 Ontruzant 1 Ogivri 1 Magnetic Resonance Spectroscopy 1 Iopamidol 1 CT-P6 1 2C4 antibody 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡